Effect of hormone therapy and raloxifene on serum VE-cadherin in postmenopausal women

Fertility and Sterility
George E ChristodoulakosGeorge C Creatsas

Abstract

To investigate the effect of continuous combined hormone therapy and raloxifene on serum VE-cadherin. The study was double blinded, with a placebo run-in period of 28-50 days. University menopause clinic. Twenty-eight healthy postmenopausal women devoid of climacteric complaints. Subjects were randomized to 17beta-estradiol (2 mg) + norethisterone acetate (1 mg; E(2)-NETA) or raloxifene hCL (60 mg) for a period of 6 months. Serum VE-cadherin, which was estimated at baseline and at month 6. Serum VE-cadherin decreased significantly in both E(2)-NETA and raloxifene groups (raloxifene baseline +/- SD: 1.17 +/- 0.44 ng/mL, 6 months: 0.82 +/- 0.29 ng/mL; E(2)-NETA baseline: 1.19 +/- 0.47 ng/mL, 6 months: 0.92 +/- 0.49 ng/mL). Percentage changes from baseline were -21.7 +/- 24.3 for E(2)-NETA and -26.0 +/- 20.6 for raloxifene. The effect of E(2)-NETA and raloxifene suggests that these drugs may preserve interendothelial junction integrity and control vascular permeability. Although this effect may influence the progress of the atheromatous lesion, its clinical impact on coronary artery disease (CAD) remains uncertain.

References

May 26, 1998·JAMA : the Journal of the American Medical Association·B W WalshP W Anderson
Dec 12, 2001·Cardiovascular Research·E P Moiseeva
Feb 16, 2002·Heart·N T Mulvihill, J B Foley
Mar 28, 2002·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·G ChristodoulakosG Creatsas
Jun 19, 2002·Trends in Cardiovascular Medicine·Burkhard LudewigHans Hengartner
May 3, 2003·The Journal of Clinical Endocrinology and Metabolism·Nicola ColacurciGiuseppe Paolisso

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.